Bellwether Trials In Xarelto Bleeding Lawsuits Schedule By Federal Judge

Print

Xarelto Bleeding Lawsuits Contend Users Of The Blood Thinner Are At Risk For Significant Bleeding Events With No Reversal Agent To Stop The Effects Of The Anticoagulant.

xarelto-bleeding-lawsuits-Wright-and-Schulte-LLCThe federal judge managing the multidistrict litigation in the U.S. District Court, Eastern District of Louisiana for Xarelto bleeding lawsuits has scheduled four bellwether trials for next year. The attoneys at Wright & Schulte LLC who are currently representing clients in blood thinner lawsuits note that after a status conference with plaintiffs’ and defendants’ attorneys, U.S. District Judge Eldon Fallon issued a Minute Entry on June 22 indicating that the first trial would be held on August 1, 2016, the second trial on August 22, 2016, the third trial on September 12, 2016 and the fourth trial on October 17, 2016. Judge Fallon suggested that the first two trials take place in the Louisiana federal court, the third trial would take place in the Southern District of Texas, and the fourth trial would take place in the Southern District of Mississippi, according to the Minute Entry. Judge Fallon also proposed the parties select 50 plaintiffs for potential bellwether cases. The Xarelto lawsuits pending in the litigation allege that plaintiffs who use the blood-thinner medication suffered severe or fatal bleeding and there was no antidote available to reverse Xarelto’s bleeding side effects. (In re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL 2592)

“Selecting cases for bellwether trials is an important process, these cases are representative of the larger group of lawsuits pending in the litigation,” says Wright & Schulte LLC, which is representing plaintiffs in the Xarelto litigation and others who have been injured by the harmful side effects from prescription drugs. “The outcome of bellwether trials gives the court, plaintiffs and defendants an indication of what similar cases may bring.”

Court documents indicate that Judge Eldon E. Fallon issued a Case Management Order (CMO) in May that directed attorneys for plaintiffs and defendants to meet prior to June 15 to develop procedures for identifying a pool of between 40 and 60 plaintiffs for specific discovery and to address the procedures and timing to select the bellwether cases from that pool. Judge Fallon ordered the parties to submit their proposals by June 30. (In re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL 2592)

As stated in court documents and by the U.S. Food and Drug Administration (FDA), Xarelto (rivaroxaban) is an anticoagulant used to reduce the risk of blood clots and stroke in patients with atrial fibrillation not caused by a heart valve problem. Xarelto was initially approved in 2011 by the FDA, which considers Xarelto a new generation blood thinner compared to warfarin (Coumadin, Jantoven), which received FDA approval 60 years ago. According to the FDA, newer anticoagulants like Xarelto and its competitor, Pradaxa, are more convenient for patients to use and patients do not need to have regular monitoring of their blood like patients who use warfarin. However, the FDA explains that unlike warfarin, Xarelto does not have an antidote to reverse its effects should significant bleeding occur in patients. Warfarin uses vitamin K as a reversal agent to stop the bleeding, according to the FDA.

The law firm comments that besides not having an antidote, a recent study found that Xarelto and Pradaxa may carry a higher risk of gastrointestinal bleeding than warfarin. A study conducted by researchers at Johns Hopkins showed that patients who took Xarelto had a twofold greater risk of experiencing gastrointestinal bleeding and as much as a 50 percent increased risk of gastrointestinal bleeding with Pradaxa compared to warfarin. The findings, published in the British Medical Journal, used data on 46,163 patients who took Xarelto, Pradaxa and warfarin from October 1, 2010 through March 31, 2012.

About Wright & Schulte LLC

Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Xarelto side effects lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
865 S. Dixie Dr.
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.